LLLT and Russian Electrical Stimulation in Osteoarthritis

NCT04788706 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-03-09

No results posted yet for this study

Summary

Objectives: To investigate the effect of low-level laser therapy (LLLT) application combined with Russian Electrical Stimulation on pain, mobility, functionality, range of motion, muscular strength, and activity in patients with osteoarthritis of the knee.

Design: Randomized controlled double-blind study. Setting: Specialist Rehabilitation Services.

Conditions

  • Osteo Arthritis Knee

Interventions

OTHER

Low level Laser Therapy and Russian electrical stimulation

LLLT over three weeks followed by an eight-week receiving Russian electrical stimulation

OTHER

Placebo Laser and Russian electrical stimulation

Placebo laser over three weeks followed by an eight-week receiving Russian electrical stimulation

OTHER

Low level Laser Therapy and Low level Laser Therapy plus Russian electrical stimulation

LLLT over three weeks followed by an eight-week receiving LLLT application combined with Russian electrical stimulation

OTHER

Placebo Laser and Placebo Laser plus Russian electrical stimulation

Placebo laser over three weeks followed by an eight-week receiving Placebo laser application combined with Russian electrical stimulation

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Patricia P Alfredo, PhD · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04788706 on ClinicalTrials.gov